HIGH EXPRESSION OF EXOGENOUS CDNAS DIRECTED BY HIV-1 LONG TERMINAL REPEAT IN HUMAN-CELLS CONSTITUTIVELY PRODUCING HIV-1 TAT AND ADENOVIRUS E1A/E1B

被引:0
作者
NEGRINI, M
RIMESSI, P
SABBIONI, S
CAPUTO, A
BALBONI, PG
GUALANDRI, R
MANSERVIGI, R
GROSSI, MP
BARBANTIBRODANO, G
机构
关键词
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A eukaryotic vector-host cell system is described where the additive transactivating effects of HIV-1 tat and adenovirus E1A on HIV-1 long terminal repeat (LTR) are exploited to increase expression of exogenous cDNAs. Human 143B and 293 cells, the latter constitutively producing E1A, were used as host cell lines. The bacterial gene chloramphenicol acetyltransferase (CAT) and the hepatitis B surface antigen (HBs-Ag) gene were employed as reporter genes inserted in pRPneoU3R, an episomal vector containing BK virus replication origin and early region, where cDNAs are expressed under control of HIV-1 LTR. The 293 cells were transformed by tat expression vectors to constitutively express tat. Stable cell clones of 293tat cells, constitutively expressing CAT after transformation with pRPneoU3R-CAT, show a CAT activity 600-fold higher than normal 293 transformed cells. CAT expression obtained in normal 293 cells can be transiently increased 10-fold by transfection by vectors expressing tat. The 293tat cells transformed by pRPneoU3R-HBs, an episomal vector expressing HBs-Ag from HIV LTR, yielded stable cell clones secreting HBs-Ag in the culture medium at a concentration up to 744 ng/ml or 44 ng/10(6) cells/24 h, 48-fold more than normal 293 cells. The use of this system for constitutive or inducible expression of sequences under control of HIV-1 LTR is discussed in view of possible applications for diagnostic, vaccinal and therapeutic purposes.
引用
收藏
页码:344 / &
相关论文
共 48 条
[1]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[2]  
BERKNER KL, 1988, BIOTECHNIQUES, V6, P616
[3]   EXPRESSION OF HEPATITIS-B SURFACE-ANTIGEN IN HUMAN-CELLS BY A RECOMBINANT BK VIRUS-DNA VECTOR [J].
CAPUTO, A ;
BARBANTIBRODANO, G ;
RESCHIGLIAN, P ;
GIANNI, M ;
MOTTES, M ;
MIRANDA, P ;
MILANESI, G ;
KNOWLES, BB ;
RICCIARDI, RP .
JOURNAL OF GENERAL VIROLOGY, 1988, 69 :459-466
[4]  
CROCE CM, 1979, J CELL PHYSL, V36, P59
[5]   TRANSACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS OCCURS VIA A BIMODAL MECHANISM [J].
CULLEN, BR .
CELL, 1986, 46 (07) :973-982
[6]   THE TRANSACTIVATOR GENE OF THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III IS REQUIRED FOR REPLICATION [J].
DAYTON, AI ;
SODROSKI, JG ;
ROSEN, CA ;
GOH, WC ;
HASELTINE, WA .
CELL, 1986, 44 (06) :941-947
[7]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[8]   HTLV-III EXPRESSION AND PRODUCTION INVOLVE COMPLEX REGULATION AT THE LEVELS OF SPLICING AND TRANSLATION OF VIRAL-RNA [J].
FEINBERG, MB ;
JARRETT, RF ;
ALDOVINI, A ;
GALLO, RC ;
WONGSTAAL, F .
CELL, 1986, 46 (06) :807-817
[9]   THE TRANSACTIVATOR GENE OF HTLV-III IS ESSENTIAL FOR VIRUS-REPLICATION [J].
FISHER, AG ;
FEINBERG, MB ;
JOSEPHS, SF ;
HARPER, ME ;
MARSELLE, LM ;
REYES, G ;
GONDA, MA ;
ALDOVINI, A ;
DEBOUK, C ;
GALLO, RC ;
WONGSTAAL, F .
NATURE, 1986, 320 (6060) :367-371
[10]   CELLULAR UPTAKE OF THE TAT PROTEIN FROM HUMAN IMMUNODEFICIENCY VIRUS [J].
FRANKEL, AD ;
PABO, CO .
CELL, 1988, 55 (06) :1189-1193